Moreover, statistically significant differences were found between NGAL concentrations in male T2DM patients prior to the implementation of insulin therapy in relation to this protein concentration in the same subjects after a 6-month insulin treatment period. This evidence concerns the gene LCN2 and type 2 diabetes mellitus.